Showing results (191-200 of 260) with videos related to

Sort By:
Pageof 26
Infection|March 27, 2015
Comparison of clinical characteristics of tuberculosis between two age groups at an Italian Tertiary HospitalElda Righi, Paola Della Siega, Maria Merelli, et al.
Infectious Diseases and Therapy|February 7, 2020
Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?Antonio Vena, Patricia Muñoz, Miriam Mateos, et al.
Journal of Neurovirology|August 20, 2017
Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature reviewElda Righi, Alessia Carnelutti, Daniele Muser, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2021
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunctionMatteo Rinaldi, Pier Giorgio Cojutti, Eleonora Zamparini, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2017
Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignanciesPier Giorgio Cojutti, Anna Candoni, Virginia Ramos-Martin, et al.
The Pediatric Infectious Disease Journal|July 31, 2023
Relationship Between Real-time TDM-guided Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam Monotherapy and Microbiologic Outcome in the Treatment of Critically Ill Children With Severe Documented Gram-negative InfectionsMilo Gatti, Caterina Campoli, Maria Elena Latrofa, et al.
Basic & Clinical Pharmacology & Toxicology|November 18, 2015
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP InducersPiergiorgio Cojutti, Anna Candoni, Fabio Forghieri, et al.
Clinical Pharmacokinetics|July 29, 2003
Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemiaFederico Pea, Domenico Russo, Mariagrazia Michieli, et al.
International Journal of Antimicrobial Agents|December 23, 2008
Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicinPierluigi Viale, Mario Furlanut, Luigia Scudeller, et al.
Journal of Global Antimicrobial Resistance|May 21, 2026
Genome Sequence of a Methicillin-Resistant Staphylococcus epidermidis (MRSE) Resistant to Dalbavancin and Teicoplanin isolated in Italy, 2023Carlo Tascini, Michela Bulfoni, Simone Giuliano, et al.
Pageof 26